More than one vaccine for Covid-19 is vital, Glaxo CEO says
‘It normally takes a decade … to develop a vaccine but we are in an unprecedented situation and the need is incredibly urgent,’ Emma Walmsley says
15 April 2020 - 09:35
London — The world will need more than one Covid-19 vaccine so drug companies must partner in the race to develop the weapons to fight the novel coronavirus, GlaxoSmithKline CEO Emma Walmsley said on Wednesday.
Glaxo and Sanofi said on Tuesday they would develop a vaccine to fight the fast-spreading coronavirus. The drugmakers said they expected to start clinical trials for the vaccine in the second half of 2020. If successful, the vaccine would be available in the second half of 2021...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.